Recent News

• 11.20.2025 - Equillium to Participate in Upcoming Investor Conferences
• 11.13.2025 - Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
• 11.03.2025 - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.22.2025 - Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
• 10.06.2025 - Equillium Announces Leadership and Corporate Updates

Recent Filings

• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - EX-99.1 EX-99.1
• 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - 8-K Current report
• 11.13.2025 - S-3 Registration statement under Securities Act of 1933
• 10.24.2025 - 8-K/A Current report
• 10.06.2025 - 8-K Current report
• 09.19.2025 - 424B5 Prospectus [Rule 424(b)(5)]